OPRM1 and head and neck squamous cell carcinoma: Gorur et al. [30] recently studied the effect of DAMGO ([D-Ala2,N-Me-Phe4,Gly5-ol]]-enkephalin), a MOR-selective agonist on HNSCC cell lines.